Viral Fusion Protein Inhibitors

All categories
DBCAT000219Pharmacologic class

Drugs that are designed to block the action of VIRAL FUSION PROTEINS and prevent VIRUSES from entering the cell. A DrugBank category of 6 drugs. 3 of them are approved.

Part of
Antiviral Agents
Drugs

What you can answer from here — as of August 16, 2018

6DrugsEach linked to its full drug card
Listed above
4Drug targetsEvery drug–target pair in the class, with bond type
Sign in
94Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
3Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Viral Fusion Protein Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In